Uncategorized

What’s in a Word?

What’s in a Word?

February 22, 2017

Cisgender? Transgender? Intersex? There’s much to talk about in sexual health and ASHA sorts out the terminology.

Continue Reading »

Beyond the Carnal Tango

Beyond the Carnal Tango

February 22, 2017

ASHA’s podcast features a conversation on men’s sexual health with ASHA board member Dr. Abe Morgentaler.

Continue Reading »

Advocate for Women’s Rights with ASHA

Advocate for Women’s Rights with ASHA

February 16, 2017

Get involved! Become an Ambassador and help us spread the word about positive, safe, and scientifically-based sexual health for women.

Continue Reading »

Why We Need to Talk to Girls about Sex

Why We Need to Talk to Girls about Sex

February 15, 2017

Check out this Tedx Talks video on the importance of talking to adolescent girls about sex.

Continue Reading »

National Condom Month

National Condom Month

February 1, 2017

ASHA recognizes each February as National Condom Month. Follow us all month long at #CondomMonth and take advantage of everything we offer: How to Use a Condom Talking to a Partner about Condoms and Safer Sex Get the Right Size Condom! Condomology: a collection of fact-based information (including fact sheets and videos) in simple, easy-to-understand […]

Continue Reading »

One Step Closer: FDA Panel Recommends Approval for Drug to Treat Women’s Low Sexual Desire

One Step Closer: FDA Panel Recommends Approval for Drug to Treat Women’s Low Sexual Desire

June 5, 2015

On June 4, 2015, an FDA advisory committee recommended approval of flibanserin, a drug to treat low sexual desire (known as hypoactive sexual desire disorder or HSDD) in women. The committee did make its approval contingent of steps being made to make women aware of the potential side effects of the drug, including low blood […]

Continue Reading »

ASHA Speaks Out on Female Sexual Dysfunction at the FDA

ASHA Speaks Out on Female Sexual Dysfunction at the FDA

November 5, 2014

On October 27, the Food and Drug Administration conducted a patient-focused public meeting on female sexual dysfunction (FSD), with a special focus on female sexual interest/arousal disorder (FSIAD). The meeting included personal stories from patients on the impact of FSD on their lives and relationships as well as comments from advocates on the need for […]

Continue Reading »

Back to Top

0